Understanding barriers to Borrelia burgdorferi dissemination during infection using massively parallel sequencing

Infection and Immunity

Volumn 81, Issue 7, 2013, Pages 2347-2357

  Troy, Erin B ^a   Lin, Tao ^b   Lazinski, David W ^c   Camilli, Andrew ^c   Norris, Steven J ^b   Hu, Linden T ^a  

^a TUFTS MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BACTERIUM ISOLATION; BORRELIA BURGDORFERI; CONTROLLED STUDY; DNA SEQUENCE; GENE SEQUENCE; HIGH THROUGHPUT SEQUENCING; IN VITRO STUDY; INNATE IMMUNITY; LYME DISEASE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TRANSPOSON;

ANIMALS; BACTERIAL LOAD; BACTERIAL PROTEINS; BORRELIA BURGDORFERI; CARRIER PROTEINS; CULTURE MEDIA; FEMALE; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PATHOGEN INTERACTIONS; IMMUNITY, INNATE; LIPOPROTEINS; LYME DISEASE; MICE; MICE, INBRED C57BL; MICROBIAL VIABILITY; MUTAGENESIS, INSERTIONAL; MYELOID DIFFERENTIATION FACTOR 88; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SKIN;

EID: 84879440478     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00266-13     Document Type: Article

References (67)

1. Hodzic E, Feng S, Freet KJ, Borjesson DL, Barthold SW. 2002. Borrelia burgdorferi population kinetics and selected gene expression at the hostvector interface. Infect. Immun. 70:3382-3388.
2. Pahl A, Kuhlbrandt U, Brune K, Rollinghoff M, Gessner A. 1999. Quantitative detection of Borrelia burgdorferi by real-time PCR. J. Clin. Microbiol. 37:1958-1963.
3. Barthold SW, Persing DH, Armstrong AL, Peeples RA. 1991. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am. J. Pathol. 139:263-273.
4. Moriarty TJ, Norman MU, Colarusso P, Bankhead T, Kubes P, Chaconas G. 2008. Real-time high resolution 3D imaging of the lyme disease spirochete adhering to and escaping from the vasculature of a living host. PLoS Pathog. 4:e1000090. doi:10.1371/journal.ppat.1000090.
5. Revel AT, Talaat AM, Norgard MV. 2002. DNA microarray analysis of differential gene expression in Borrelia burgdorferi, the Lyme disease spirochete. Proc. Natl. Acad. Sci. U. S. A. 99:1562-1567.
6. Brooks CS, Hefty PS, Jolliff SE, Akins DR. 2003. Global analysis of Borrelia burgdorferi genes regulated by mammalian host-specific signals. Infect. Immun. 71:3371-3383.
7. Coutte L, Botkin DJ, Gao L, Norris SJ. 2009. Detailed analysis of sequence changes occurring during vlsE antigenic variation in the mouse model of Borrelia burgdorferi infection. PLoS Pathog. 5:e1000293.doi:10.1371/journal.ppat.1000293.
8. Schwartz DJ, Chen SL, Hultgren SJ, Seed PC. 2011. Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection. Infect. Immun. 79:4250-4259.
9. Oberle M, Balmer O, Brun R, Roditi I. 2010. Bottlenecks and the maintenance of minor genotypes during the life cycle of Trypanosoma brucei. PLoS Pathog. 6:e1001023.doi:10.1371/journal.ppat.1001023.
10. Pfeiffer JK, Kirkegaard K. 2006. Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc. Natl. Acad. Sci. U. S. A. 103:5520-5525.
11. Barnes PD, Bergman MA, Mecsas J, Isberg RR. 2006. Yersinia pseudotuberculosis disseminates directly from a replicating bacterial pool in the intestine. J. Exp. Med. 203:1591-1601.
12. Kuss SK, Etheredge CA, Pfeiffer JK. 2008. Multiple host barriers restrict poliovirus trafficking in mice. PLoS Pathog. 4:e1000082. doi:10.1371/journal.ppat.1000082.
13. Ali A, Li H, Schneider WL, Sherman DJ, Gray S, Smith D, Roossinck MJ. 2006. Analysis of genetic bottlenecks during horizontal transmission of Cucumber mosaic virus. J. Virol. 80:8345-8350.
14. Ali A, Roossinck MJ. 2010. Genetic bottlenecks during systemic movement of Cucumber mosaic virus vary in different host plants. Virology 404:279-283.
15. Bergstrom CT, McElhany P, Real LA. 1999. Transmission bottlenecks as determinants of virulence in rapidly evolving pathogens. Proc. Natl. Acad. Sci. U. S. A. 96:5095-5100.
16. Handel A, Bennett MR. 2008. Surviving the bottleneck: transmission mutants and the evolution of microbial populations. Genetics. 180:2193-2200.
17. Mackinnon MJ, Bell A, Read AF. 2005. The effects of mosquito transmission and population bottlenecking on virulence, multiplication rate and rosetting in rodent malaria. Int. J. Parasitol. 35:145-153.
18. Li H, Roossinck MJ. 2004. Genetic bottlenecks reduce population variation in an experimental RNA virus population. J. Virol. 78:10582-10587.
19. Sacristan S, Malpica JM, Fraile A, Garcia-Arenal F. 2003. Estimation of population bottlenecks during systemic movement of tobacco mosaic virus in tobacco plants. J. Virol. 77:9906-9911.
20. Hodzic E, Feng S, Freet KJ, Barthold SW. 2003. Borrelia burgdorferi population dynamics and prototype gene expression during infection of immunocompetent and immunodeficient mice. Infect. Immun. 71:5042-5055.
21. Gawronski JD, Wong SM, Giannoukos G, Ward DV, Akerley BJ. 2009. Tracking insertion mutants within libraries by deep sequencing and a genome-wide screen for Haemophilus genes required in the lung. Proc. Natl. Acad. Sci. U. S. A. 106:16422-16427.
22. Goodman AL, McNulty NP, Zhao Y, Leip D, Mitra RD, Lozupone CA, Knight R, Gordon JI. 2009. Identifying genetic determinants needed to establish a human gut symbiont in its habitat. Cell Host Microbe 6:279-289.
23. van Opijnen T, Bodi KL, Camilli A. 2009. Tn-seq: high-throughput parallel sequencing for fitness and genetic interaction studies in microorganisms. Nat. Methods 6:767-772.
24. Gallagher LA, Shendure J, Manoil C. 2011. Genome-Scale Identification of Resistance Functions in Pseudomonas aeruginosa Using Tn-seq. mBio 2:e00315-10. doi:10.1128/mBio.00315-10.
25. Klein BA, Tenorio EL, Lazinski DW, Camilli A, Duncan MJ, Hu LT. 2012. Identification of essential genes of the periodontal pathogen Porphyromonas gingivalis. BMC Genomics 13:578. doi:10.1186/1471-2164-13-578.
26. Kawabata H, Norris SJ, Watanabe H. 2004. BBE02 disruption mutants of Borrelia burgdorferi B31 have a highly transformable, infectious phenotype. Infect. Immun. 72:7147-7154.
27. Lin T, Gao L, Zhang C, Odeh E, Jacobs MB, Coutte L, Chaconas G, Philipp MT, Norris SJ. 2012. Analysis of an ordered, comprehensive STM mutant library in infectious Borrelia burgdorferi: insights into the genes required for mouse infectivity. PLoS One 7:e47532. doi:10.1371/journal.pone.0047532.
28. Stewart PE, Rosa PA. 2008. Transposon mutagenesis of the lyme disease agent Borrelia burgdorferi. Methods Mol. Biol. 431:85-95.
29. Lin T, Gao L, Edmondson DG, Jacobs MB, Philipp MT, Norris SJ. 2009. Central role of the Holliday junction helicase RuvAB in vlsE recombination and infectivity of Borrelia burgdorferi. PLoS Pathog. 5:e1000679. doi:10.1371/journal.ppat.1000679.
30. Stewart PE, Hoff J, Fischer E, Krum JG, Rosa PA. 2004. Genome-wide transposon mutagenesis of Borrelia burgdorferi for identification of phenotypic mutants. Appl. Environ. Microbiol. 70:5973-5979.
31. Norris SJ, Howell JK, Odeh EA, Lin T, Gao L, Edmondson DG. 2011. High-throughput plasmid content analysis of Borrelia burgdorferi B31 by using Luminex multiplex technology. Appl. Environ. Microbiol. 77:1483-1492.
32. Purser JE, Norris SJ. 2000. Correlation between plasmid content and infectivity in Borrelia burgdorferi. Proc. Natl. Acad. Sci. U. S. A. 97:13865-13870.
33. Giardine B, Riemer C, Hardison RC, Burhans R, Elnitski L, Shah P, Zhang Y, Blankenberg D, Albert I, Taylor J, Miller W, Kent WJ, Nekrutenko A. 2005. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15:1451-1455.
34. Goecks J, Nekrutenko A, Taylor J, Galaxy Team. 2010. Galaxy: a comprehensive approach for supporting accessible, reproducible, and transparent computational research in the life sciences. Genome Biol. 11:R86-2010-11-8-r86.
35. Blankenberg D, Von Kuster G, Coraor N, Ananda G, Lazarus R, Mangan M, Nekrutenko A, Taylor J. 2010. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. 19:19.10.1-19.10.21.
36. Wang XG, Kidder JM, Scagliotti JP, Klempner MS, Noring R, Hu LT. 2004. Analysis of differences in the functional properties of the substrate binding proteins of the Borrelia burgdorferi oligopeptide permease (opp) operon. J. Bacteriol. 186:51-60.
37. Lin B, Short SA, Eskildsen M, Klempner MS, Hu LT. 2001. Functional testing of putative oligopeptide permease (Opp) proteins of Borrelia burgdorferi: a complementation model in opp(_) Escherichia coli. Biochim. Biophys. Acta 1499:222-231.
38. Wang XG, Lin B, Kidder JM, Telford S, Hu LT. 2002. Effects of environmental changes on expression of the oligopeptide permease (opp) genes of Borrelia burgdorferi. J. Bacteriol. 184:6198-6206.
39. Pitzer JE, Sultan SZ, Hayakawa Y, Hobbs G, Miller MR, Motaleb MA.2011. Analysis of the Borrelia burgdorferi cyclic-di-GMP-binding protein PlzA reveals a role in motility and virulence. Infect. Immun. 79:1815-1825.
40. Sultan SZ, Pitzer JE, Boquoi T, Hobbs G, Miller MR, Motaleb MA. 2011. Analysis of the HD-GYP domain cyclic dimeric GMP phosphodiesterase reveals a role in motility and the enzootic life cycle of Borrelia burgdorferi. Infect. Immun. 79:3273-3283.
41. Tilly K, Krum JG, Bestor A, Jewett MW, Grimm D, Bueschel D, Byram R, Dorward D, Vanraden MJ, Stewart P, Rosa P. 2006. Borrelia burgdorferi OspC protein required exclusively in a crucial early stage of mammalian infection. Infect. Immun. 74:3554-3564.
42. Steere AC. 2001. Lyme disease. N. Engl. J. Med. 345:115-125.
43. Grimm D, Elias AF, Tilly K, Rosa PA. 2003. Plasmid stability during in vitro propagation of Borrelia burgdorferi assessed at a clonal level. Infect. Immun. 71:3138-3145.
44. Bolz DD, Sundsbak RS, Ma Y, Akira S, Kirschning CJ, Zachary JF, Weis JH, Weis JJ. 2004. MyD88 plays a unique role in host defense but not arthritis development in Lyme disease. J. Immunol. 173:2003-2010.
45. Binder SC, Telschow A, Meyer-Hermann M. 2012. Population dynamics of Borrelia burgdorferi in Lyme disease. Front. Microbiol. 3:104.
46. Swanson KI, Norris DE. 2008. Presence of multiple variants of Borrelia burgdorferi in the natural reservoir Peromyscus leucopus throughout a transmission season. Vector Borne Zoonotic Dis. 8:397-405.
47. Guttman DS, Wang PW, Wang IN, Bosler EM, Luft BJ, Dykhuizen DE. 1996. Multiple infections of Ixodes scapularis ticks by Borrelia burgdorferi as revealed by single-strand conformation polymorphism analysis. J. Clin. Microbiol. 34:652-656.
48. Anderson JM, Norris DE. 2006. Genetic diversity of Borrelia burgdorferi sensu stricto in Peromyscus leucopus, the primary reservoir of Lyme disease in a region of endemicity in southern Maryland. Appl. Environ. Microbiol. 72:5331-5341.
49. Kurtenbach K, De Michelis S, Sewell HS, Etti S, Schafer SM, Hails R, Collares-Pereira M, Santos-Reis M, Hanincova K, Labuda M, Bormane A, Donaghy M. 2001. Distinct combinations of Borrelia burgdorferi sensu lato genospecies found in individual questing ticks from Europe. Appl. Environ. Microbiol. 67:4926-4929.
50. Liveris D, Varde S, Iyer R, Koenig S, Bittker S, Cooper D, McKenna D, Nowakowski J, Nadelman RB, Wormser GP, Schwartz I. 1999. Genetic diversity of Borrelia burgdorferi in Lyme disease patients as determined by culture versus direct PCR with clinical specimens. J. Clin. Microbiol. 37: 565-569.
51. Ruzic-Sabljic E, Arnez M, Logar M, Maraspin V, Lotric-Furlan S, Cimperman J, Strle F. 2005. Comparison of Borrelia burgdorferi sensu lato strains isolated from specimens obtained simultaneously from two different sites of infection in individual patients. J. Clin. Microbiol. 43: 2194-2200.
52. Liveris D, Gazumyan A, Schwartz I. 1995. Molecular typing of Borrelia burgdorferi sensu lato by PCR-restriction fragment length polymorphism analysis. J. Clin. Microbiol. 33:589-595.
53. Seinost G, Dykhuizen DE, Dattwyler RJ, Golde WT, Dunn JJ, Wang IN, Wormser GP, Schriefer ME, Luft BJ. 1999. Four clones of Borrelia burgdorferi sensu stricto cause invasive infection in humans. Infect. Immun. 67:3518-3524.
54. Wang IN, Dykhuizen DE, Qiu W, Dunn JJ, Bosler EM, Luft BJ. 1999. Genetic diversity of ospC in a local population of Borrelia burgdorferi sensu stricto. Genetics 151:15-30.
55. Wilske B, Busch U, Fingerle V, Jauris-Heipke S, Preac Mursic V, Rossler D, Will G. 1996. Immunological and molecular variability of OspA and OspC. Implications for Borrelia vaccine development. Infection 24:208-212.
56. Brisson D, Baxamusa N, Schwartz I, Wormser GP. 2011. Biodiversity of Borrelia burgdorferi strains in tissues of Lyme disease patients. PLoS One 6:e22926.doi:10.1371/journal.pone.0022926.
57. Wormser GP, Brisson D, Liveris D, Hanincova K, Sandigursky S, Nowakowski J, Nadelman RB, Ludin S, Schwartz I. 2008. Borrelia burgdorferi genotype predicts the capacity for hematogenous dissemination during early Lyme disease. J. Infect. Dis. 198:1358-1364.
58. Wormser GP, Liveris D, Nowakowski J, Nadelman RB, Cavaliere LF, McKenna D, Holmgren D, Schwartz I. 1999. Association of specific subtypes of Borrelia burgdorferi with hematogenous dissemination in early Lyme disease. J. Infect. Dis. 180:720-725.
59. Liu N, Montgomery RR, Barthold SW, Bockenstedt LK. 2004. Myeloid differentiation antigen 88 deficiency impairs pathogen clearance but does not alter inflammation in Borrelia burgdorferi-infected mice. Infect. Immun. 72:3195-3203.
60. Cruz AR, Moore MW, La Vake CJ, Eggers CH, Salazar JC, Radolf JD. 2008. Phagocytosis of Borrelia burgdorferi, the Lyme disease spirochete, potentiates innate immune activation and induces apoptosis in human monocytes. Infect. Immun. 76:56-70.
61. Shin OS, Isberg RR, Akira S, Uematsu S, Behera AK, Hu LT. 2008. Distinct roles for MyD88 and Toll-like receptors 2, 5, and 9 in phagocytosis of Borrelia burgdorferi and cytokine induction. Infect. Immun. 76: 2341-2351.
62. Samuels DS. 2011. Gene regulation in Borrelia burgdorferi. Annu. Rev. Microbiol. 65:479-499.
63. Dunham-Ems SM, Caimano MJ, Pal U, Wolgemuth CW, Eggers CH, Balic A, Radolf JD. 2009. Live imaging reveals a biphasic mode of dissemination of Borrelia burgdorferi within ticks. J. Clin. Invest. 119:3652-3665.
64. Ramamoorthi N, Narasimhan S, Pal U, Bao F, Yang XF, Fish D, Anguita J, Norgard MV, Kantor FS, Anderson JF, Koski RA, Fikrig E. 2005. The Lyme disease agent exploits a tick protein to infect the mammalian host. Nature 436:573-577.
65. Hovius JW. 2009. Spitting image: tick saliva assists the causative agent of Lyme disease in evading host skin's innate immune response. J. Investig. Dermatol. 129:2337-2339.
66. Hovius JWR, de Jong MAWP, den Dunnen J, Litjens M, Fikrig E, van der Poll T, Gringhuis SI, Geijtenbeek TBH. 2008. Salp15 binding to DC-SIGN inhibits cytokine expression by impairing both nucleosome remodeling and mRNA stabilization. PLoS Pathog. 4:e31. doi:10.1371/journal.ppat.0040031.
67. Montgomery RR, Lusitani D, De Boisfleury Chevance A, Malawista SE. 2004. Tick saliva reduces adherence and area of human neutrophils. Infect. Immun. 72:2989-2994.